person
Ann J.
- Country
- Belgium
- Department
- Hematology
Research Overview
assignment
28
Clinical Trials ·
- Phase 1 Evaluation of BMS-986416 with and without Nivolumab in Patients with Solid Tumors
- Phase I Evaluation of ABBV-525, a MALT1 Inhibitor, in Patients with B-Cell Malignancies
- A Phase 1/2 Study of Enzomenib (DSP 5336) in Adults with Relapsed or Refractory Acute Leukemia, Including MLL-Rearranged or NPM1-Mutated Subtypes
location_city
5
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
344
Sites with multiple studies
Has run more than one trial at 344 of 582 partner sites.
Specializations
Lung Cancer Expertise
This investigator specializes in treating various stages of non-small cell lung cancer (NSCLC), with particular focus on early-stage disease management and surgical interventions.
- Stage IB-IIIA NSCLC treatment
- Post-surgical adjuvant therapy
- RET fusion-positive NSCLC management
Thoracic Oncology
The investigator demonstrates expertise in treating rare thoracic malignancies, including thymic carcinoma and thymoma, particularly focusing on advanced cases requiring specialized treatment approaches.
- Type B3 thymoma therapy
- Advanced thymic carcinoma treatment
- Solid tumor management
Hematological Malignancies
The investigator works with various blood cancers, including acute myeloid leukemia (AML), lymphomas, and multiple myeloma.
- Hematopoietic cell transplantation
- Leukemia and lymphoma treatment
- Myeloproliferative disorders
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.